Breast Cancer Drugs Market – Global Industry Perspective Comprehensive Analysis and Forecast, 2015 to 2021

Report Code: ZMR-70 | Report Format : | Status : Upcoming |

Abstract

Breast cancer is a malignant cell growth in the breast. Breast cancer can begin in different areas of the breast — the ducts, the lobules, or in some cases, the tissue. Sign of breast cancer include lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple etc.  Breast cancer most commonly develops in cell from the lining of milk ducts and the lobules that supply the ducts with milk. Cancers developing from the ducts are known as ductal carcinomas, while those developing from lobules are known as lobular carcinomas. Breast cancer is the most common cancer among women worldwide and the second-most common cancer overall. Incidence of breast cancer rise after the age 50 who have been through the menopause. About 8 out of 10 cases of breast cancer occur in women over the age of 50. Diagnosis of breast cancer is confirmed by physical examination, imaging test, or taking biopsy.

Breast cancer market is driven by increasing incidence of cancer cases (% increase in elder women in all countries) across globe. Moreover, increasing awareness, government initiative, and improved health care facilities influence the breast cancer drug market. However, high cost of treatment and limited awareness are major restraining factors in the growth of breast cancer drug market over the years. Nonetheless, ongoing research and development in the healthcare sector coupled with advancement in medical technologies is expected to open growth avenues for the market over the years.

The report covers forecast and analysis of the breast cancer drug market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million).  To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the breast cancer drug market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein treatment segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides detailed segmentation of the breast cancer drug market based on treatment and region.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Demand has been analyzed and forecast based on the current trends for the period of six years. North America and Europe were the leading regional segments of breast cancer drug market in 2015 on account of the high number of reported cases and easy affordability of the drugs in these regions. Moreover, technological advancement and strong demand of diagnostic test would also account for market growth. The breast cancer drug market is expected to witness the highest growth in Asia-Pacific region in upcoming years due to excessive increase of health care infrastructure, growing percentage of population, and increase in disposal income among the population.

The report covers scenario including the company overviews, financial revenues of the key participants. Key players of breast cancer drug market included in report are GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd, Actavis, Inc., Bristol-Myers Squibb Company, Hospira, Inc., Bayer AG, Accord Healthcare, Inc. and Gilead Sciences, Inc. 

This report segments the breast cancer drug market are follows:

Breast Cancer Drug Market: Treatment Segment Analysis

  • Targeted therapy
  • Chemotherapy
  • Surgery & radiation therapy
  • Hormonal therapy

Breast Cancer Drug Market: Regional Segment Analysis

  • North America
  • Europe
  • Asia pacific
  • Latin America
  • Middle east & Africa

Related Reports

Respiratory Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1464 | Report Format:

Global Respiratory Diagnostics Market: Overview People from every corner of the world may have suffered from some kind of respiratory diseases. Respiratory diseases may result in death if they are not properly diagnosed. Commonly prevalent respiratory diseases include asthma, acute respiratory i...Read More

Dermal Filler Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1449 | Report Format:

Global Dermal Filler Market: Overview Treatment for various skin related problems is done through dermal filler procedures. Removal of wrinkles, scars, skin smoothening and other procedures can be done through dermal filler procedure. Though fearing the side effects, the growth in this market ma...Read More

Curcumin Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1412 | Report Format:

Global Curcumin Market: Overview A chemical that is bright yellow in color is curcumin which is produced by some of the plants. It is found in the turmeric. They are mainly sold as food coloring, cosmetic supplement, herbal supplement, and food flavoring. The common application of the curcumin i...Read More

Point-of-Care Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1406 | Report Format:

Global Point-of-Care Diagnostics Market: Overview The point-of-care (POC) diagnostics deals with the medical devices that are used to get immediate outcomes in the investigation of the different diseases such as diabetes, cancer, cardiac diseases, and others. There are different types of POC dev...Read More

Contrast Media/Contrast Agent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1359 | Report Format:

Global Contrast Media/Contrast Agent Market: Overview To enhance the contrast of the structures or fluids inside the body contrast medium or the contrast agent is used in the medical imaging. The anatomical organs and structures are imaged better as the image contrast is increased. Thus, it is v...Read More

Choose License Type:
Latest Published Reports

View All Published Reports